Evershine Capital

Evershine Capital invests across the venture lifecycle, from seed and startup rounds through expansion and late-stage growth equity. The firm's multi-stage approach means it can write first checks into early-stage companies and continue supporting portfolio companies through subsequent financing rounds. This flexibility allows the firm to maintain ownership stakes as companies scale.

The firm maintains a generalist technology mandate with confirmed coverage of enterprise software, artificial intelligence and machine learning, digital health, and fintech. Unlike many Chinese venture firms that concentrate on single verticals such as semiconductors or biotech, Evershine operates across multiple technology subsectors, pursuing opportunities wherever it identifies scalable, tech-enabled business models in mainland China.

Based on the firm's disclosed strategy and Shanghai headquarters, Evershine Capital invests domestically within mainland China. The firm focuses on China's technology ecosystem, where venture dynamics — including onshore-offshore structuring, variable interest entity (VIE) considerations, and sector-specific regulatory oversight — differ materially from other Asian markets. There is no public indication of cross-border investment activity.

Evershine Capital operates as an independent asset manager rather than a single-family office or corporate venture arm. The firm has not publicly disclosed its limited partner base or named anchor investors. Most renminbi-denominated venture firms of this profile raise capital from a mix of domestic institutional investors, high-net-worth individuals, and government guidance funds, though Evershine's specific LP composition remains private.

The firm has made no public disclosures regarding co-investment policies or whether it syndicates deals with external general partners. As a multi-stage venture investor, Evershine may co-invest alongside other firms in larger growth rounds or lead rounds independently at the seed stage, but without portfolio-level transparency, allocators should inquire directly about syndication practices and decision rights on follow-on rounds.